Dr John Weight Loss Pharmacy - Recent Posts

Recent Posts

03 August 2025
Australia’s TGA has approved Wegovy, Mounjaro, Zepbound , and other medications for weight loss, giving patients broader treatment options. Wegovy officially launched in August 2024 and demand continu...

03 August 2025
A new drug candidate called MariTide , taken just once a month, achieved up to 16% weight loss in early trials. If approved, it could simplify treatment compared to weekly injections like Wegovy or Mo...

03 August 2025
Researchers found that medications like Ozempic and Wegovy may reduce the risk of developing dementia by up to 37% in patients with type 2 diabetes—an unexpected bonus to their weight loss and metabol...

03 August 2025
A large global study confirmed that Mounjaro (tirzepatide) reduces the risk of heart attack, stroke, and cardiovascular-related death in people with type 2 diabetes. It's not just for weight loss—it's...

03 August 2025
Observational studies suggest GLP-1 receptor agonists—including semaglutide and tirzepatide—might reduce risk of dementia (by 37%), stroke (19%), and overall mortality (30%) in overweight patients wit...

03 August 2025
A large global trial involving over 13,000 patients revealed that Mounjaro reduced the risk of heart attack, stroke, and cardiovascular death by 8% compared to Trulicity. It also improved kidney funct...

03 August 2025
Introduction: In the battle against obesity and type 2 diabetes, Mounjaro and Ozempic have emerged as two leading injectable medications. Both offer promising results, but which one is more effectiv...

03 August 2025
If available, share testimonials or case studies to boost credibility and engagement.

03 August 2025
Help users get the most from their medication with tips on diet, adherence, and medical supervision.

03 August 2025
Educate your customers on how to verify sources, check packaging, and avoid counterfeits.